1. Home
  2. IPGP vs SUPN Comparison

IPGP vs SUPN Comparison

Compare IPGP & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IPG Photonics Corporation

IPGP

IPG Photonics Corporation

HOLD

Current Price

$153.46

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.56

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPGP
SUPN
Founded
1990
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.8B
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
IPGP
SUPN
Price
$153.46
$50.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$122.17
$61.60
AVG Volume (30 Days)
681.7K
716.9K
Earning Date
02-12-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.73
N/A
Revenue
$1,003,777,000.00
$681,539,000.00
Revenue This Year
$6.40
$8.18
Revenue Next Year
$8.15
$22.15
P/E Ratio
$210.84
N/A
Revenue Growth
2.73
4.54
52 Week Low
$48.59
$29.16
52 Week High
$155.82
$57.65

Technical Indicators

Market Signals
Indicator
IPGP
SUPN
Relative Strength Index (RSI) 83.61 49.96
Support Level $108.27 $49.76
Resistance Level $154.21 $51.99
Average True Range (ATR) 7.64 1.40
MACD 4.83 0.08
Stochastic Oscillator 81.88 54.04

Price Performance

Historical Comparison
IPGP
SUPN

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company operates in one segment which involves the design, development, production and distribution of fiber lasers, laser and non-laser systems, fiber amplifiers, and related optical components. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from North America and also has its presence in China, Japan, Germany, and other markets.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: